P&K Skin Research Center Co. Ltd
P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vi… Read more
P&K Skin Research Center Co. Ltd (347740) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.021x
Based on the latest financial reports, P&K Skin Research Center Co. Ltd (347740) has a cash flow conversion efficiency ratio of 0.021x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.70 Billion) by net assets (₩81.39 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
P&K Skin Research Center Co. Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how P&K Skin Research Center Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
P&K Skin Research Center Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of P&K Skin Research Center Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
R K Swamy Limited
NSE:RKSWAMY
|
N/A |
|
Zaigle Co. Ltd
KQ:234920
|
-0.099x |
|
Formula
TA:FORTY
|
0.009x |
|
KB Autosys Co. Ltd
KQ:024120
|
-0.009x |
|
Tripar Multivision Plus
JK:RAAM
|
0.042x |
|
Handok Clean Tech Co. Ltd
KQ:256150
|
0.036x |
|
Cincon Electronics Co Ltd
TWO:3332
|
0.024x |
|
Teract S.A.
PA:TRACT
|
0.439x |
Annual Cash Flow Conversion Efficiency for P&K Skin Research Center Co. Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of P&K Skin Research Center Co. Ltd from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩76.94 Billion | ₩9.03 Billion | 0.117x | +57.07% |
| 2023-12-31 | ₩74.24 Billion | ₩5.55 Billion | 0.075x | -29.50% |
| 2022-12-31 | ₩70.81 Billion | ₩7.51 Billion | 0.106x | -13.13% |
| 2021-12-31 | ₩63.07 Billion | ₩7.70 Billion | 0.122x | -21.66% |
| 2020-12-31 | ₩55.63 Billion | ₩8.67 Billion | 0.156x | -41.24% |
| 2019-12-31 | ₩24.50 Billion | ₩6.49 Billion | 0.265x | -0.76% |
| 2018-12-31 | ₩15.96 Billion | ₩4.26 Billion | 0.267x | -- |